Skip to content

E3 and Profile

by Diagnosys LLC

510(k) K221471

Active European Union and United States

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK221471 Date22 Nov 2022ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
20 May 2022
FDA decision
22 Nov 2022 (Substantially Equivalent)
FDA review time
186 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K221471 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K221471 decided 22 Nov 2022 Active
  • EUDAMED Active

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
GWE
FDA applicant
Diagnosys, LLC
Device class
Class II
Regulation
21 CFR Part 882.1890
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The E3 and Profile is a Photic Evoked Response Stimulator, designed to elicit and record visual evoked potentials (VEPs) in response to controlled light stimuli. It is classified under the regulatory category for evoked response photic stimulators, facilitating objective assessment of visual pathway function in clinical and research settings.

This system is supplied as a desktop visual electrophysiology unit paired with a mobile companion device, intended for use in neurology and ophthalmology clinics. Sterility is not applicable as it is a reusable medical device, though it must be cleaned and maintained per manufacturer guidelines. The device operates under FDA 510(k) clearance (K221471) and complies with the Medical Device Directive (MDD), regulated under 21 CFR 882.1890 as a Class II device with product code GWE.

Devices cleared under K221471

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K221471
UDI-DISize and differences
Espion D310
DIAGNOSYS LLC
D31000855730007290 —On the market
Espion D315
DIAGNOSYS LLC
D31500855730007306 —On the market

Similar devices

Other devices filed under FDA product code GWE (Stimulator, Photic, Evoked Response).

Other devices from Diagnosys LLC

See all devices from Diagnosys LLC →